source
- Anthropic’s Claude AI designs miniproteins from scratch in new studyAnthropic announced that its AI system Claude was used to design and generate miniproteins from scratch in a recent research campaign. The study showed Claude could propose novel protein sequences…
- Amgen ends partnership with TScan Therapeutics as Amylyx announces $350 million offeringAmgen announced it is terminating its collaboration with TScan Therapeutics, a Waltham, Massachusetts company focused on T‑cell therapies. The decision ends a partnership that had been aimed at de…